comparemela.com

Page 15 - Organon Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why Is Organon Stock Trading Higher On Thursday? - Organon (NYSE:OGN)

Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, driven by Follistim AQ's 63% growth. Biosimilar revenue surges by 49%.

Do You Believe That Organon & Co (OGN) is a Compelling Prospect for Long-Term, Patient Investors?

Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2023. A copy of the same can be downloaded here. The fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 12.43% and 12.50%, respectively, in the fourth quarter of 2023, outperforming the Russell 1000 Value Index’s (Russell Value) 9.50% […]

Short Interest in Organon & Co (NYSE:OGN) Decreases By 10 7%

Organon & Co. (NYSE:OGN – Get Free Report) saw a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 12,330,000 shares, a decrease of 10.7% from the January 15th total of 13,810,000 shares. Approximately 4.8% of the shares of the company are short sold. Based […]

Lord Abbett & CO LLC Trims Stock Holdings in Organon & Co (NYSE:OGN)

Lord Abbett & CO. LLC lessened its holdings in Organon & Co. (NYSE:OGN – Free Report) by 3.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,028,350 shares of the company’s stock after selling 202,689 shares during the quarter. Lord […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.